The differential distributions of CD8+ T cells, Tfh cells, and Th17 cells associating with the prognosis of HNSCC patients with high or low expression of PRAS40 solidified our conclusion that PRAS40 could be a tumor suppressor in HNSCC patients. Here, AKT1S1 is linked to head and neck squamous cell carcinoma.